Dr. Margaret MacMillan, MD
Claim this profileUniversity of Minnesota Masonic Cancer Center
Area of expertise
Bone Marrow Failure Syndrome
Margaret MacMillan, MD has run 4 trials for Bone Marrow Failure Syndrome. Some of their research focus areas include:
Myelodysplastic Syndrome
Margaret MacMillan, MD has run 3 trials for Myelodysplastic Syndrome. Some of their research focus areas include:
Affiliated Hospitals
University Of Minnesota/Masonic Cancer Center
University Of Minnesota
Clinical Trials Margaret MacMillan, MD is currently running
TCD HCT
for Fanconi Anemia
This is a phase II trial of T cell receptor alpha/beta depletion (α/β TCD) peripheral blood stem cell (PBSC) transplantation in patients with inherited bone marrow failure (BMF) disorders to eliminate the need for routine graft-versus-host disease (GVHD) immune suppression leading to earlier immune recovery and potentially a reduction in the risk of severe infections after transplantation.
Recruiting
3 awards
Phase 2
8 criteria
Stem Cell Transplantation
for Blood Cancers
This is a phase II, open-label, prospective study of T cell receptor alpha/beta depletion (TCR α/β TCD) peripheral blood stem cell (PBSC) transplantation for children and adults with hematological malignancies. This is a safety/feasibility study of the investigational procedure/product.
Recruiting
1 award
Phase 2
More about Margaret MacMillan, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Margaret MacMillan, MD has experience with
- Fludarabine
- RP-L102
- T Cell Receptor Α/β TCD HCT
- Cyclophosphamide
- Sirolimus
- TBI
Breakdown of trials Margaret MacMillan, MD has run
Bone Marrow Failure Syndrome
Myelodysplastic Syndrome
Bone Marrow Failure
Acute Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margaret MacMillan, MD specialize in?
Margaret MacMillan, MD focuses on Bone Marrow Failure Syndrome and Myelodysplastic Syndrome. In particular, much of their work with Bone Marrow Failure Syndrome has involved FANCA positive patients, or patients who are Stage IV.
Is Margaret MacMillan, MD currently recruiting for clinical trials?
Yes, Margaret MacMillan, MD is currently recruiting for 2 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Margaret MacMillan, MD has studied deeply?
Yes, Margaret MacMillan, MD has studied treatments such as Fludarabine, RP-L102, T Cell Receptor α/β TCD HCT.
What is the best way to schedule an appointment with Margaret MacMillan, MD?
Apply for one of the trials that Margaret MacMillan, MD is conducting.
What is the office address of Margaret MacMillan, MD?
The office of Margaret MacMillan, MD is located at: University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455 United States. This is the address for their practice at the University of Minnesota Masonic Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.